artículo

• Induction of the inflammasome by the SARS-CoV-2 accessory protein ORF9b, abrogated by small-molecule ORF9b homodimerization inhibitors 2024
• Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10 2024
• Autochthonous Peruvian Natural Plants as Potential SARS-CoV-2 Mpro Main Protease Inhibitors 2023
• Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarction 2023
• On the importance for drug discovery of a transnational Latin American database of natural compound structures 2023
• A novel gene signature unveils three distinct immune-metabolic rewiring patterns conserved across diverse tumor types and associated with outcomes 2022
• Recovery of serum testosterone levels is an accurate predictor of survival from COVID-19 in male patients 2022
• Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 Mpro Protease through Virtual Screening 2021
• Potential Protective Effect from COVID-19 Conferred by Altitude: A Longitudinal Analysis in Peru During Full Lockdown 2021
• C1 esterase inhibitor and the contact system in COVID-19 2020
• Metabolic Alterations in Cardiopulmonary Vascular Dysfunction 2019
• Metabolic Plasticity and Epithelial-Mesenchymal Transition 2019
• The Tumor Microenvironment in Colorectal Cancer Therapy 2019
• Epithelial plasticity in cancer: beyond metastasis 2018
• Model-driven discovery of long-chain fatty acid metabolic reprogramming in heterogeneous prostate cancer cells 2018
• Untargeted metabolomics reveals distinct metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell subpopulations 2018
• De novo MYC addiction as an adaptive response of cancer cells to CDK4/6 inhibition 2017
• MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells 2017